Belite Bio (BLTE) Short Interest Ratio & Short Volume

Short interest is the volume of Belite Bio shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 232,300 shares of BLTE short. Learn More on Belite Bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BLTE shares currently have a short interest ratio of 3.0. Learn More on Belite Bio's short interest ratio.

Belite Bio saw a drop in short interest during the month of November. As of November 30th, there was short interest totaling 232,300 shares, a drop of 3.6% from the previous total of 241,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Belite Bio: Jazz Pharmaceuticals plc (7.34%), Madrigal Pharmaceuticals, Inc. (19.62%), Legend Biotech Co. (13.04%), Nuvalent, Inc. (12.26%), Ionis Pharmaceuticals, Inc. (7.18%), Blueprint Medicines Co. (6.60%), Elanco Animal Health Incorporated (3.15%), Cytokinetics, Incorporated (12.35%), Corcept Therapeutics Incorporated (18.90%), TG Therapeutics, Inc. (20.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

Short selling BLTE is an investing strategy that aims to generate trading profit from Belite Bio as its price is falling. BLTE shares are trading down $0.37 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Belite Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLTE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLTE, twice per month. The most recent reporting period available is November, 30 2024.